Skip to Content

Two Billion COVID-19 Vaccine Doses From BioNTech Expected This Year

MONDAY, Jan. 11, 2021 -- A boost in manufacturing should enable Germany's BioNTech to produce 2 billion doses of its COVID-19 vaccine this year, the company says.

BioNTech and partner Pfizer developed the first COVID-19 vaccination to be brought to market.

With three manufacturing sites in the United States and three in Europe operating or starting up soon, BioNTech expects to about double the number of doses available for this fiscal year, according to company CEO and cofounder Ugur Sahin, the Associated Press reported. The company is also looking to widen eligibility for the vaccine -- which was 95 percent effective in trials -- to include pregnant women, children, and others.

As of Jan 10, 32.9 million doses of its vaccine had been shipped, according to BioNTech, the AP reported. The vaccine has to be stored at extremely cold temperatures, but the company said it is working on a more stable version for easier use in remote regions.

Associated Press Article

© 2021 HealthDay. All rights reserved.

Posted: January 2021

Read this next

U.S. to Get Fewer Vials of Pfizer COVID-19 Vaccine

MONDAY, Jan. 25, 2021 -- Pfizer will provide fewer vials of its COVID-19 vaccine to the United States in the coming months after it was discovered that it had previously shipped...

Moderna COVID-19 Vaccine Effective Against British, South African Variants

MONDAY, Jan. 25, 2021 -- Moderna says its COVID-19 vaccine remains effective against two worrisome new coronavirus variants from Britain and South Africa, but it is somewhat less...

Fauci Awarded Medal by Academy of Sciences

MONDAY, Jan. 25, 2021 -- Anthony Fauci, M.D., will receive the 2021 Public Welfare Medal for his "decades-long leadership in combating emerging infectious diseases, from the AIDS...

More News Resources

Subscribe to our Newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.